Prot# A3871028: A Phase 2, Multi-Center, Open Label, Long-Term Extension Trial to Assess the Safety and Sustained Efficacy of Oral UK-390,957 Administered as Required in Adult Men with Premature Ejaculation

Project: Research project

Project Details

StatusFinished
Effective start/end date3/28/05 → 6/28/05

Funding

  • Pfizer Inc. (A3871028)